Anti-C (RH2) 210527
by Diagast
Anti-C (RH2) 210527 is an anti-C [RH002] red blood cell grouping IVD made by Diagast, listed in FDA GUDID since 1 May 2018 (UDI-DI 23661562105278), registry data as of 23 Oct 2026.
Listed
Valid until
Not applicable
FDA recalls
Not checked
Documents
None
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number23661562105278 | Date1 May 2018 | StatusListed |
Official records
- AccessGUDID record 23661562105278
From the FDA record
- Device description
- Blood Grouping Reagent, Anti-C (Human/Murine Monoclonal) (P3X25513G8+MS24) - This reagent is designed to determine the presence of the blood group antigen C (Rh2) on the surface of human red blood cells by manual tube method.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- Labelled as containing natural rubber latex
- Sterility
- Supplied non-sterile
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — GUDID listing Listed
Specification
- Trade name
- Anti-C (RH2)
- Generic name
- Anti-C [RH002] red blood cell grouping IVD, antibody
- Model / Ref / Catalog
- 210527
- Primary DI / UDI-DI
- 23661562105278
- GMDN term
- Anti-C [RH002] red blood cell grouping IVD, antibody
- GUDID distribution status
- In Commercial Distribution